漢康-KY創 7827
Listed · Biotechnology and medical care119▼-1 (-0.83%)After close
- Prev close
- 120
- Volume (shares)
- 106,481
- Data time
- 2026-11-11 13:30:00
- Open
- 118.50
- High
- 119.00
- Low
- 116.50
- Prev close
- 120.00
- Volume (lots)
- 106
- Turnover
- 0.13 億
- P/E
- —
- Cash yield
- —
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Gross margin | 6.50% | — | — | 100.00% | — | — | — |
| Operating margin | -2,867.30% | — | — | 39.20% | — | — | — |
| Net margin | -2,739.72% | — | — | 22.58% | — | — | — |
| ROE (TTM) | -86.31% | — | -61.71% | — | — | — | — |
| ROA (TTM) | -60.27% | — | -45.70% | — | — | -244.10% | — |
| EPS, quarter (TWD) | -1.88 | -2.10 | -0.94 | 0.59 | — | — | — |
| EPS, TTM (TWD) | -4.33 | — | -2.26 | — | — | -20.36 | -1.85 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-09 | 0.0 | — | -100.00% | 0.3 | -91.14% |
| 2026-08 | 0.0 | -100.00% | — | 0.3 | — |
| 2026-07 | 0.2 | — | — | 0.3 | — |
| 2026-06 | 0.0 | — | — | 0.1 | — |
| 2026-05 | 0.0 | -100.00% | — | 0.1 | — |
| 2026-04 | 0.1 | — | — | 0.1 | — |
| 2026-03 | 0.0 | — | — | 0.0 | — |
| 2026-02 | 0.0 | — | — | 0.0 | — |
| 2026-01 | 0.0 | — | — | 0.0 | — |
| 2025-12 | 0.0 | — | — | 3.1 | — |
| 2025-11 | 0.0 | — | — | 3.1 | — |
| 2025-10 | 0.0 | -100.00% | — | 3.1 | — |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.0 | 0.0 | 3.1 | — | — | — |
| Cost of revenue | 0.1 | 0.0 | 0.0 | 0.0 | — | — | — |
| Gross profit | 0.0 | 0.0 | 0.0 | 3.1 | — | — | — |
| Operating expenses | 2.7 | 3.2 | 2.5 | 1.9 | — | — | — |
| Operating income | -2.7 | -3.2 | -2.5 | 1.2 | — | — | — |
| Non-operating items | 0.1 | -0.0 | 0.1 | -0.2 | — | — | — |
| Pre-tax income | -2.6 | -3.2 | -2.4 | 1.0 | — | — | — |
| Income tax | 0.0 | 0.1 | -0.1 | — | — | — | — |
| Continuing operations | -2.6 | -3.3 | -2.3 | 0.7 | — | — | — |
| Net income | -2.6 | -3.3 | -2.3 | 0.7 | — | — | — |
| Net income to parent | -2.5 | -2.7 | -1.2 | 0.7 | — | — | — |
| Net income to NCI | -0.1 | -0.6 | -1.1 | 0.0 | — | — | — |
| Other comprehensive income | 0.1 | 0.1 | 0.4 | -0.0 | — | — | — |
| Total comprehensive income | -2.5 | -3.2 | -1.9 | 0.7 | — | — | — |
| EPS (TWD) | -1.88 | -2.10 | -0.94 | 0.59 | — | — | — |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Current assets | 18.2 | 8.8 | 10.8 | 12.4 | 4.6 | 4.3 | 4.4 |
| Non-current assets | 1.3 | 0.8 | 0.9 | 0.9 | 0.9 | 1.1 | 1.3 |
| Total assets | 19.5 | 9.7 | 11.7 | 13.3 | 5.5 | 5.4 | 5.7 |
| Current liabilities | 4.5 | 3.8 | 3.0 | 2.6 | 2.6 | 3.0 | 2.2 |
| Non-current liabilities | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 17.2 |
| Total liabilities | 4.8 | 3.8 | 3.0 | 2.6 | 2.6 | 3.1 | 19.4 |
| Share capital | 14.0 | 13.0 | 13.0 | 13.0 | 12.0 | 12.0 | 0.2 |
| Capital surplus | 36.6 | 26.1 | 25.8 | 25.8 | 19.9 | 19.9 | 1.3 |
| Retained earnings | -36.3 | -33.8 | -31.1 | -29.9 | -30.6 | -28.3 | -14.7 |
| Other equity | -1.0 | -1.1 | -1.2 | -1.4 | -1.3 | -1.3 | -0.5 |
| Treasury stock | 0.0 | 0.0 | -0.0 | -0.0 | -0.0 | — | — |
| Equity to parent | 13.3 | 4.3 | 6.7 | 7.6 | 0.0 | 2.3 | -13.7 |
| Non-controlling interests | 1.4 | 1.5 | 2.0 | 3.0 | 2.9 | 0.0 | 0.0 |
| Total equity | 14.7 | 5.8 | 8.7 | 10.7 | 2.9 | 2.3 | -13.7 |
| Book value per share (TWD) | 9.47 | 3.29 | 5.12 | 5.86 | 0.01 | 1.93 | -601.66 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -2.4 | -2.3 | -1.6 | 1.1 | — | — | — |
| Investing cash flow | 0.4 | -0.5 | 0.3 | -0.5 | — | — | — |
| Financing cash flow | 11.3 | 0.1 | -0.1 | 8.2 | — | — | — |
| FX effect | 0.1 | 0.1 | 0.4 | 0.1 | — | — | — |
| Net change in cash | 9.4 | -2.5 | -1.1 | 8.9 | — | — | — |
| Cash, beginning | 10.6 | 10.6 | 4.1 | 4.1 | 4.1 | 3.4 | 2.5 |
| Cash, ending | 17.6 | 8.2 | 10.6 | 11.7 | 2.8 | 4.1 | 3.4 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Current ratio | 409.33% | — | — | — | — | — | — |
| Debt ratio | 24.64% | 39.80% | 25.81% | 19.69% | 46.83% | 57.34% | 341.48% |
| Equity ratio | 75.36% | 60.20% | 74.19% | 80.31% | 53.17% | 42.66% | -241.48% |
| Equity multiplier | 1.33 | 1.66 | 1.35 | 1.25 | 1.88 | 2.34 | -0.41 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.26 | — | 0.36 | — | — | — | 0.00 |
| Equity turnover | 0.36 | — | -1.25 | — | — | — | -0.00 |
Source: MOPS. For reference only; not investment advice.